rs142881576
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000337836.10(C6):c.1786C>T(p.Arg596Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000868 in 1,613,406 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000337836.10 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C6 | NM_000065.5 | c.1786C>T | p.Arg596Ter | stop_gained | 12/18 | ENST00000337836.10 | NP_000056.2 | |
LOC105374739 | XR_001742650.2 | n.887-2161G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C6 | ENST00000337836.10 | c.1786C>T | p.Arg596Ter | stop_gained | 12/18 | 1 | NM_000065.5 | ENSP00000338861 | P1 | |
C6 | ENST00000263413.7 | c.1786C>T | p.Arg596Ter | stop_gained | 12/18 | 1 | ENSP00000263413 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 151812Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000144 AC: 36AN: 250704Hom.: 0 AF XY: 0.000148 AC XY: 20AN XY: 135458
GnomAD4 exome AF: 0.0000828 AC: 121AN: 1461476Hom.: 0 Cov.: 32 AF XY: 0.0000963 AC XY: 70AN XY: 727034
GnomAD4 genome AF: 0.000125 AC: 19AN: 151930Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74258
ClinVar
Submissions by phenotype
Complement component 6 deficiency Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 10, 2014 | The Arg596X variant in C6 has not been previously reported in individuals with disease and has been identified in 2/8600 European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs142881576). This nonsense variant leads to a premature termination codon at position 596 which is predicted to lead to a truncated or absent protein. Loss of function variants in C6 leading to deficiency of C6 have been associated with increased susceptibility to neisserial infections, especially meningitis. In summary, although additional studies are required to fully establish its clinical significance, the Arg596X variant is likely pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 29, 2022 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | This sequence change creates a premature translational stop signal (p.Arg596*) in the C6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in C6 are known to be pathogenic (PMID: 17257682). This variant is present in population databases (rs142881576, gnomAD 0.2%). This premature translational stop signal has been observed in individual(s) with complement deficiency (PMID: 31440263). ClinVar contains an entry for this variant (Variation ID: 208565). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at